Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
BOSTON Jan. 13, 2026 /PRNewswire/ -- Magnet Biomedicine, a leading induced-proximity biotech company advancing rational molecular glue discovery, today announced the appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer. Dr. Vlahakis will oversee clinical development and medical strategy for the company's pipeline of molecular glue inhibitors. "Nick's appointment comes at a pivotal moment for Magnet," said Brian Safina, Ph.D., Chief Executive Officer of Magnet Biomedicine. "As we advance our molecular glue inhibitor programs toward the clinic, his strategic leadership will be instrumental in establishing a clear path to human proof-of-concept and reinforcing our position as a pioneer in induced proximity-derived medicines delivering convenient oral alternatives to standard of care biologics for I&I diseases, cancer and beyond." "Effectively addressing the continuing unmet need in complex I&I diseases demands innovation," said Nick Vlahakis, M.B.B.S., Chief Medical Offi
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche [Yahoo! Finance]Yahoo! Finance
- A Look At Roche Holding's (SWX:ROG) Valuation As TIGIT And AI Pathology Progress Draw Fresh Attention [Yahoo! Finance]Yahoo! Finance
- Roche (OTCMKTS:RHHBY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Immunotherapy and AI Biomarker Advances Might Change The Case For Investing In Roche Holding (SWX:ROG) [Yahoo! Finance]Yahoo! Finance
- Roche (OTCMKTS:RHHBY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.MarketBeat